Press Releases
Press Releases
Showing 1–10 of 11 posts
-
05.19.23 -
Press Releases
05.02.23 Metagenomi to Present New Data for Its Novel Gene-Editing Systems at the 26th American Society of Gene + Cell Therapy (ASGCT) Annual Meeting
-
Press Releases
03.06.23 Metagenomi Announces Participation in March Investor Conferences
-
Press Releases
03.02.23 Metagenomi Recognized as One of World’s Most Innovative Companies by Fast Company
-
Press Releases
02.14.23 Metagenomi Appoints Sarah Noonberg, M.D., Ph.D. as Chief Medical Officer
-
Press Releases
01.05.23 Metagenomi Closes Oversubscribed Series B Financing Totaling $275M to Advance Lead Therapeutic Programs into Clinical Development and Grow Genetic Medicines Pipeline
-
Press Releases
01.03.23 Metagenomi to Present at 41st Annual J.P. Morgan Healthcare Conference
-
Press Releases
11.22.22 Metagenomi Named an Endpoints 11 Winner
-
Press Releases
11.14.22 Ionis Partners with Metagenomi to Add Gene Editing to its Broad Technology Platform
-
Press Releases
06.15.22 Affini-T Therapeutics & Metagenomi Announce Next-Generation Gene Editing Partnership to Advance Cell Therapies for Solid Tumor Patients